327 related articles for article (PubMed ID: 7690926)
1. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
Marchetti D; Parikh N; Sudol M; Gallick GE
Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
[TBL] [Abstract][Full Text] [Related]
3. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.
Han NM; Curley SA; Gallick GE
Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313
[TBL] [Abstract][Full Text] [Related]
5. Expression of C-terminal src kinase in human colorectal cancer cell lines.
Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
[TBL] [Abstract][Full Text] [Related]
6. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of p62c-yes in normal, hyperplastic and neoplastic human epidermis.
Krueger J; Zhao YH; Murphy D; Sudol M
Oncogene; 1991 Jun; 6(6):933-40. PubMed ID: 2067846
[TBL] [Abstract][Full Text] [Related]
8. Loss of c-kit expression in cultured melanoma cells.
Lassam N; Bickford S
Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
[TBL] [Abstract][Full Text] [Related]
9. pp60c-src in human melanocytes and melanoma cells exhibits elevated specific activity and reduced tyrosine 530 phosphorylation compared to human fibroblast pp60c-src.
O'Connor TJ; Neufeld E; Bechberger J; Fujita DJ
Cell Growth Differ; 1992 Jul; 3(7):435-42. PubMed ID: 1384653
[TBL] [Abstract][Full Text] [Related]
10. c-yes protein kinase is associated with a 38 kD protein in cerebellum.
Grandori C; Sudol M; Hanafusa H
Oncogene; 1991 Jun; 6(6):1063-6. PubMed ID: 2067844
[TBL] [Abstract][Full Text] [Related]
11. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
[TBL] [Abstract][Full Text] [Related]
12. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification, and initial characterization of human Yes protein tyrosine kinase from a bacterial expression system.
Sun G; Budde RJ
Arch Biochem Biophys; 1997 Sep; 345(1):135-42. PubMed ID: 9281320
[TBL] [Abstract][Full Text] [Related]
14. A novel Yes-related kinase, Yrk, is expressed at elevated levels in neural and hematopoietic tissues.
Sudol M; Greulich H; Newman L; Sarkar A; Sukegawa J; Yamamoto T
Oncogene; 1993 Apr; 8(4):823-31. PubMed ID: 8455940
[TBL] [Abstract][Full Text] [Related]
15. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product.
Ottenhoff-Kalff AE; Rijksen G; van Beurden EA; Hennipman A; Michels AA; Staal GE
Cancer Res; 1992 Sep; 52(17):4773-8. PubMed ID: 1380891
[TBL] [Abstract][Full Text] [Related]
16. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
[TBL] [Abstract][Full Text] [Related]
17. Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53.
Chenevix-Trench G; Martin NG; Ellem KA
Oncogene; 1990 Aug; 5(8):1187-93. PubMed ID: 1697409
[TBL] [Abstract][Full Text] [Related]
18. Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma.
Masaki T; Okada M; Tokuda M; Shiratori Y; Hatase O; Shirai M; Nishioka M; Omata M
Hepatology; 1999 Feb; 29(2):379-84. PubMed ID: 9918913
[TBL] [Abstract][Full Text] [Related]
19. Expression of cellular-yes protein in mammalian tissues.
Zhao YH; Krueger JG; Sudol M
Oncogene; 1990 Nov; 5(11):1629-35. PubMed ID: 2267131
[TBL] [Abstract][Full Text] [Related]
20. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
